Published in

Wiley, Clinical and Experimental Dermatology, 4(47), p. 783-785, 2022

DOI: 10.1111/ced.15061

Links

Tools

Export citation

Search in Google Scholar

Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab

Journal article published in 2022 by Antonio Carriero ORCID, Ennio Lubrano ORCID, Valentina Picerno, Angela Anna Padula, Salvatore D’Angelo ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Abstract Paradoxical psoriatic arthritis (PPsA) may be associated with guselkumab treatment. We describe a patient in whom PPsA required a change from guselkumab to ixekizumab. The pathophysiology of this paradoxical reaction is most likely a cytokine imbalance.